![Safety, Tolerability and Pharmacokinetics Following Single- and Multiple-Dose Administration of the Novel NNRTI MK-8507 With a Midazolam Interaction Arm Safety, Tolerability and Pharmacokinetics Following Single- and Multiple-Dose Administration of the Novel NNRTI MK-8507 With a Midazolam Interaction Arm](https://www.natap.org/2020/images/101220/101220-3/1012201.gif)
Safety, Tolerability and Pharmacokinetics Following Single- and Multiple-Dose Administration of the Novel NNRTI MK-8507 With a Midazolam Interaction Arm
![MK-8507 plasma PK following administration of single oral MK-8507 doses... | Download Scientific Diagram MK-8507 plasma PK following administration of single oral MK-8507 doses... | Download Scientific Diagram](https://www.researchgate.net/publication/354565004/figure/fig1/AS:1108577276174336@1641316827728/MK-8507-plasma-PK-following-administration-of-single-oral-MK-8507-doses-in-adults-without.png)
MK-8507 plasma PK following administration of single oral MK-8507 doses... | Download Scientific Diagram
![Merck Provides Update on Phase 2 Clinical Trial of Once-Weekly Investigational Combination of MK-8507 and Islatravir for the Treatment of People Living with HIV-1 | Business Wire Merck Provides Update on Phase 2 Clinical Trial of Once-Weekly Investigational Combination of MK-8507 and Islatravir for the Treatment of People Living with HIV-1 | Business Wire](https://mms.businesswire.com/media/20211118006392/en/1106824/23/Merck_Logo_Horizontal_Teal%26Grey_RGB.jpg)
Merck Provides Update on Phase 2 Clinical Trial of Once-Weekly Investigational Combination of MK-8507 and Islatravir for the Treatment of People Living with HIV-1 | Business Wire
![Investigational ART - Expert Analysis - Highlights - 2020 HIV Glasgow - 人类免疫缺陷病毒 - Clinical Care Options Investigational ART - Expert Analysis - Highlights - 2020 HIV Glasgow - 人类免疫缺陷病毒 - Clinical Care Options](https://www.clinicaloptions.com/-/media/hiv/conferences/glasgow-2020/module-thumbs/glasgow_expert_analysis_thumb-21.png?rev=65d4a5e854a84955bd2f56024b738ba1)
Investigational ART - Expert Analysis - Highlights - 2020 HIV Glasgow - 人类免疫缺陷病毒 - Clinical Care Options
![Design of single and multiple once-weekly rising-dose trial of MK-8507... | Download Scientific Diagram Design of single and multiple once-weekly rising-dose trial of MK-8507... | Download Scientific Diagram](https://www.researchgate.net/publication/354565004/figure/tbl2/AS:1108577276182534@1641316827790/Design-of-single-and-multiple-once-weekly-rising-dose-trial-of-MK-8507-with-midazolam.png)